SPARC-positive macrophages are the superior prognostic factor in the microenvironment of diffuse large B-cell lymphoma and independent of MYC rearrangement and double-/triple-hit status-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SPARC-positive macrophages are the superior prognostic factor in the microenvironment of diffuse large B-cell lymphoma and independent of MYC rearrangement and double-/triple-hit status

Published:2021-11 Issue:11 Volume:32 Page:1400-1409
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Croci G.A.,Au-Yeung R.K.H.,Reinke S.,Staiger A.M.,Koch K.,Oschlies I.,Richter J.,Poeschel V.,Held G.,Loeffler M.,Trümper L.,Rosenwald A.,Ott G.,Spang R.,Altmann B.,Ziepert M.,Klapper W.

Funder

Gilead Sciences

Amgen

German Federal Ministry of Health

Takeda Pharmaceutical Company

Novartis

Regeneron Pharmaceuticals

Deutscher Akademischer Austauschdienst France

Deutscher Akademischer Austauschdienst

Roche

Bundesministerium für Bildung und Forschung

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference44 articles.

1. International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin’s lymphoma;N Engl J Med,1993

2. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma;Rosenwald;N Engl J Med,2002

3. A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival;Hans;Blood,2003

4. Clinical impact of the cell-of-origin classification and the MYC/BCL2 dual expresser status in diffuse large B-cell lymphoma treated within prospective clinical trials of the German high-grade non-Hodgkin’s lymphoma study group;Staiger;J Clin Oncol,2017

5. Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity;Sehn;Blood,2015

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor purity-related genes for predicting the prognosis and drug sensitivity of DLBCL patients;eLife;2024-07-09

2. Tumor purity-related genes for predicting the prognosis and drug sensitivity of DLBCL patients;eLife;2024-07-09

3. Tumor Purity-Related Genes for Predicting the Prognosis and Drug Sensitivity of DLBCL Patients;2024-06-19

4. Spatially-resolved transcriptomics reveal macrophage heterogeneity and prognostic significance in diffuse large B-cell lymphoma;Nature Communications;2024-03-08

5. Tumor Purity-Related Genes for Predicting the Prognosis and Drug Sensitivity of DLBCL Patients;2024-01-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3